ASGD5
MCID: ANT085
MIFTS: 25

Anterior Segment Dysgenesis 5 (ASGD5)

Categories: Cardiovascular diseases, Eye diseases, Fetal diseases, Genetic diseases, Rare diseases

Aliases & Classifications for Anterior Segment Dysgenesis 5

MalaCards integrated aliases for Anterior Segment Dysgenesis 5:

Name: Anterior Segment Dysgenesis 5 57 75
Anterior Segment Dysgenesis 5, Multiple Subtypes 57 6
Asgd5 57 75

Characteristics:

HPO:

32
anterior segment dysgenesis 5:
Inheritance autosomal recessive inheritance


Classifications:



Summaries for Anterior Segment Dysgenesis 5

OMIM : 57 Anterior segment dysgeneses (ASGD or ASMD) are a heterogeneous group of developmental disorders affecting the anterior segment of the eye, including the cornea, iris, lens, trabecular meshwork, and Schlemm canal. The clinical features of ASGD include iris hypoplasia, an enlarged or reduced corneal diameter, corneal vascularization and opacity, posterior embryotoxon, corectopia, polycoria, an abnormal iridocorneal angle, ectopia lentis, and anterior synechiae between the iris and posterior corneal surface (summary by Cheong et al., 2016). Anterior segment dysgenesis is sometimes divided into subtypes including aniridia (see 106210), Axenfeld and Rieger anomalies, iridogoniodysgenesis, Peters anomaly, and posterior embryotoxon (Gould and John, 2002). Patients with ASGD5 have been reported with the Peters anomaly, Axenfeld anomaly, and Rieger anomaly subtypes. Peters anomaly consists of a central corneal leukoma, absence of the posterior corneal stroma and Descemet membrane, and a variable degree of iris and lenticular attachments to the central aspect of the posterior cornea (Peters, 1906). It occurs as an isolated ocular abnormality or in association with other ocular defects. In Axenfeld anomaly, strands of iris tissue attach to the Schwalbe line; in Rieger anomaly, in addition to the attachment of iris tissue to the Schwalbe line, there is clinically evident iris stromal atrophy with hole or pseudo-hole formation and corectopia (summary by Smith and Traboulsi, 2012). (604229)

MalaCards based summary : Anterior Segment Dysgenesis 5, also known as anterior segment dysgenesis 5, multiple subtypes, is related to anterior segment dysgenesis and coloboma, ocular, autosomal dominant. An important gene associated with Anterior Segment Dysgenesis 5 is PAX6 (Paired Box 6). Affiliated tissues include eye and bone, and related phenotypes are nystagmus and corneal opacity

UniProtKB/Swiss-Prot : 75 Anterior segment dysgenesis 5: A form of anterior segment dysgenesis, a group of defects affecting anterior structures of the eye including cornea, iris, lens, trabecular meshwork, and Schlemm canal. Anterior segment dysgeneses result from abnormal migration or differentiation of the neural crest derived mesenchymal cells that give rise to components of the anterior chamber during eye development. Different anterior segment anomalies may exist alone or in combination, including iris hypoplasia, enlarged or reduced corneal diameter, corneal vascularization and opacity, posterior embryotoxon, corectopia, polycoria, abnormal iridocorneal angle, ectopia lentis, and anterior synechiae between the iris and posterior corneal surface. Clinical conditions falling within the phenotypic spectrum of anterior segment dysgeneses include aniridia, Axenfeld anomaly, Reiger anomaly/syndrome, Peters anomaly, and iridogoniodysgenesis.

Related Diseases for Anterior Segment Dysgenesis 5

Graphical network of the top 20 diseases related to Anterior Segment Dysgenesis 5:



Diseases related to Anterior Segment Dysgenesis 5

Symptoms & Phenotypes for Anterior Segment Dysgenesis 5

Clinical features from OMIM:

604229

Human phenotypes related to Anterior Segment Dysgenesis 5:

32
# Description HPO Frequency HPO Source Accession
1 nystagmus 32 very rare (1%) HP:0000639
2 corneal opacity 32 hallmark (90%) HP:0007957
3 strabismus 32 very rare (1%) HP:0000486
4 peters anomaly 32 HP:0000659
5 congenital glaucoma 32 frequent (33%) HP:0001087

MGI Mouse Phenotypes related to Anterior Segment Dysgenesis 5:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 neoplasm MP:0002006 8.62 CYP1B1 PAX6

Drugs & Therapeutics for Anterior Segment Dysgenesis 5

Search Clinical Trials , NIH Clinical Center for Anterior Segment Dysgenesis 5

Genetic Tests for Anterior Segment Dysgenesis 5

Anatomical Context for Anterior Segment Dysgenesis 5

MalaCards organs/tissues related to Anterior Segment Dysgenesis 5:

41
Eye, Bone

Publications for Anterior Segment Dysgenesis 5

Variations for Anterior Segment Dysgenesis 5

UniProtKB/Swiss-Prot genetic disease variations for Anterior Segment Dysgenesis 5:

75
# Symbol AA change Variation ID SNP ID
1 PAX6 p.Arg26Gly VAR_003810 rs121907913
2 PAX6 p.Val53Asp VAR_008700
3 PAX6 p.Ser363Pro VAR_017544

ClinVar genetic disease variations for Anterior Segment Dysgenesis 5:

6 (show top 50) (show all 420)
# Gene Variation Type Significance SNP ID Assembly Location
1 PAX6 NM_000280.4(PAX6): c.607C> T (p.Arg203Ter) single nucleotide variant Pathogenic rs121907916 GRCh37 Chromosome 11, 31816253: 31816253
2 PAX6 NM_000280.4(PAX6): c.607C> T (p.Arg203Ter) single nucleotide variant Pathogenic rs121907916 GRCh38 Chromosome 11, 31794705: 31794705
3 PAX6 NM_000280.4(PAX6): c.718C> T (p.Arg240Ter) single nucleotide variant Pathogenic rs121907917 GRCh37 Chromosome 11, 31815627: 31815627
4 PAX6 NM_000280.4(PAX6): c.718C> T (p.Arg240Ter) single nucleotide variant Pathogenic rs121907917 GRCh38 Chromosome 11, 31794079: 31794079
5 PAX6 NM_001604.5(PAX6): c.161T> A (p.Val54Asp) single nucleotide variant Pathogenic rs121907921 GRCh37 Chromosome 11, 31823441: 31823441
6 PAX6 NM_001604.5(PAX6): c.161T> A (p.Val54Asp) single nucleotide variant Pathogenic rs121907921 GRCh38 Chromosome 11, 31801893: 31801893
7 CYP1B1 NM_000104.3(CYP1B1): c.171G> A (p.Trp57Ter) single nucleotide variant Pathogenic/Likely pathogenic rs72549387 GRCh37 Chromosome 2, 38302361: 38302361
8 CYP1B1 NM_000104.3(CYP1B1): c.171G> A (p.Trp57Ter) single nucleotide variant Pathogenic/Likely pathogenic rs72549387 GRCh38 Chromosome 2, 38075218: 38075218
9 CYP1B1 NM_000104.3(CYP1B1): c.1103G> A (p.Arg368His) single nucleotide variant Conflicting interpretations of pathogenicity rs79204362 GRCh37 Chromosome 2, 38298394: 38298394
10 CYP1B1 NM_000104.3(CYP1B1): c.1103G> A (p.Arg368His) single nucleotide variant Conflicting interpretations of pathogenicity rs79204362 GRCh38 Chromosome 2, 38071251: 38071251
11 FREM1 NM_144966.5(FREM1): c.1493G> A (p.Arg498Gln) single nucleotide variant Likely benign rs184394424 GRCh37 Chromosome 9, 14842559: 14842559
12 FREM1 NM_144966.5(FREM1): c.1493G> A (p.Arg498Gln) single nucleotide variant Likely benign rs184394424 GRCh38 Chromosome 9, 14842561: 14842561
13 CYP1B1 NM_000104.3(CYP1B1): c.1200_1209dupTCATGCCACC (p.Thr404Serfs) duplication Pathogenic rs587778873 GRCh37 Chromosome 2, 38298288: 38298297
14 CYP1B1 NM_000104.3(CYP1B1): c.1200_1209dupTCATGCCACC (p.Thr404Serfs) duplication Pathogenic rs587778873 GRCh38 Chromosome 2, 38071145: 38071154
15 PAX6 NM_000280.4(PAX6): c.152G> T (p.Gly51Val) single nucleotide variant Pathogenic rs587778874 GRCh37 Chromosome 11, 31823314: 31823314
16 PAX6 NM_000280.4(PAX6): c.152G> T (p.Gly51Val) single nucleotide variant Pathogenic rs587778874 GRCh38 Chromosome 11, 31801766: 31801766
17 PAX6 NM_000280.4(PAX6): c.357+1G> A single nucleotide variant Pathogenic rs398123295 GRCh37 Chromosome 11, 31823108: 31823108
18 PAX6 NM_000280.4(PAX6): c.357+1G> A single nucleotide variant Pathogenic rs398123295 GRCh38 Chromosome 11, 31801560: 31801560
19 PTCH1 NM_000264.4(PTCH1): c.3947A> G (p.Tyr1316Cys) single nucleotide variant Conflicting interpretations of pathogenicity rs147067171 GRCh37 Chromosome 9, 98209591: 98209591
20 PTCH1 NM_000264.4(PTCH1): c.3947A> G (p.Tyr1316Cys) single nucleotide variant Conflicting interpretations of pathogenicity rs147067171 GRCh38 Chromosome 9, 95447309: 95447309
21 CYP1B1 NM_000104.3(CYP1B1): c.1347T> C (p.Asp449=) single nucleotide variant Benign rs1056837 GRCh37 Chromosome 2, 38298150: 38298150
22 CYP1B1 NM_000104.3(CYP1B1): c.1347T> C (p.Asp449=) single nucleotide variant Benign rs1056837 GRCh38 Chromosome 2, 38071007: 38071007
23 CYP1B1 NM_000104.3(CYP1B1): c.729G> C (p.Val243=) single nucleotide variant Benign/Likely benign rs9341249 GRCh37 Chromosome 2, 38301803: 38301803
24 CYP1B1 NM_000104.3(CYP1B1): c.729G> C (p.Val243=) single nucleotide variant Benign/Likely benign rs9341249 GRCh38 Chromosome 2, 38074660: 38074660
25 CYP1B1 NM_000104.3(CYP1B1): c.564C> A (p.Gly188=) single nucleotide variant Benign/Likely benign rs9341247 GRCh37 Chromosome 2, 38301968: 38301968
26 CYP1B1 NM_000104.3(CYP1B1): c.564C> A (p.Gly188=) single nucleotide variant Benign/Likely benign rs9341247 GRCh38 Chromosome 2, 38074825: 38074825
27 CYP1B1 NM_000104.3(CYP1B1): c.-1-12C> T single nucleotide variant Benign/Likely benign rs2617266 GRCh37 Chromosome 2, 38302544: 38302544
28 CYP1B1 NM_000104.3(CYP1B1): c.-1-12C> T single nucleotide variant Benign/Likely benign rs2617266 GRCh38 Chromosome 2, 38075401: 38075401
29 PITX2 NM_153427.2(PITX2): c.660G> A (p.Pro220=) single nucleotide variant Benign/Likely benign rs148191851 GRCh37 Chromosome 4, 111539437: 111539437
30 PITX2 NM_153427.2(PITX2): c.660G> A (p.Pro220=) single nucleotide variant Benign/Likely benign rs148191851 GRCh38 Chromosome 4, 110618281: 110618281
31 PITX2 NM_153427.2(PITX2): c.*454C> T single nucleotide variant Benign rs6533526 GRCh38 Chromosome 4, 110617671: 110617671
32 PITX2 NM_153427.2(PITX2): c.*454C> T single nucleotide variant Benign rs6533526 GRCh37 Chromosome 4, 111538827: 111538827
33 PITX2 NM_153427.2(PITX2): c.403G> A (p.Ala135Thr) single nucleotide variant Benign/Likely benign rs77144743 GRCh37 Chromosome 4, 111539694: 111539694
34 PITX2 NM_153427.2(PITX2): c.403G> A (p.Ala135Thr) single nucleotide variant Benign/Likely benign rs77144743 GRCh38 Chromosome 4, 110618538: 110618538
35 PAX6 NM_000280.4(PAX6): c.-129+9G> A single nucleotide variant Benign/Likely benign rs56139994 GRCh38 Chromosome 11, 31810819: 31810819
36 PAX6 NM_000280.4(PAX6): c.-129+9G> A single nucleotide variant Benign/Likely benign rs56139994 GRCh37 Chromosome 11, 31832367: 31832367
37 EPHB2 NM_001309193.1(EPHB2): c.787G> A (p.Val263Ile) single nucleotide variant Likely benign rs150803261 GRCh37 Chromosome 1, 23111545: 23111545
38 EPHB2 NM_001309193.1(EPHB2): c.787G> A (p.Val263Ile) single nucleotide variant Likely benign rs150803261 GRCh38 Chromosome 1, 22785052: 22785052
39 DAB1 NM_021080.3(DAB1): c.1075G> A (p.Gly359Arg) single nucleotide variant Likely benign rs746363033 GRCh38 Chromosome 1, 57015252: 57015252
40 DAB1 NM_021080.3(DAB1): c.1075G> A (p.Gly359Arg) single nucleotide variant Likely benign rs746363033 GRCh37 Chromosome 1, 57480925: 57480925
41 FAT4 NM_001291285.1(FAT4): c.131A> C (p.Glu44Ala) single nucleotide variant Likely benign rs200221425 GRCh37 Chromosome 4, 126237697: 126237697
42 FAT4 NM_001291285.1(FAT4): c.131A> C (p.Glu44Ala) single nucleotide variant Likely benign rs200221425 GRCh38 Chromosome 4, 125316542: 125316542
43 FAT1 NM_005245.3(FAT1): c.4336G> A (p.Val1446Ile) single nucleotide variant Likely benign rs200828005 GRCh37 Chromosome 4, 187549905: 187549905
44 FAT1 NM_005245.3(FAT1): c.4336G> A (p.Val1446Ile) single nucleotide variant Likely benign rs200828005 GRCh38 Chromosome 4, 186628751: 186628751
45 PTCH1 NM_000264.4(PTCH1): c.2695A> G (p.Ile899Val) single nucleotide variant Likely pathogenic rs765371196 GRCh37 Chromosome 9, 98224146: 98224146
46 PTCH1 NM_000264.4(PTCH1): c.2695A> G (p.Ile899Val) single nucleotide variant Likely pathogenic rs765371196 GRCh38 Chromosome 9, 95461864: 95461864
47 PITRM1 NM_001242307.1(PITRM1): c.2423A> G (p.Lys808Arg) single nucleotide variant Likely benign rs869025266 GRCh37 Chromosome 10, 3187825: 3187825
48 PITRM1 NM_001242307.1(PITRM1): c.2423A> G (p.Lys808Arg) single nucleotide variant Likely benign rs869025266 GRCh38 Chromosome 10, 3145633: 3145633
49 RARG NM_000966.5(RARG): c.245C> T (p.Pro82Leu) single nucleotide variant Likely benign rs769476878 GRCh37 Chromosome 12, 53609518: 53609518
50 RARG NM_000966.5(RARG): c.245C> T (p.Pro82Leu) single nucleotide variant Likely benign rs769476878 GRCh38 Chromosome 12, 53215734: 53215734

Expression for Anterior Segment Dysgenesis 5

Search GEO for disease gene expression data for Anterior Segment Dysgenesis 5.

Pathways for Anterior Segment Dysgenesis 5

GO Terms for Anterior Segment Dysgenesis 5

Biological processes related to Anterior Segment Dysgenesis 5 according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 negative regulation of cell proliferation GO:0008285 8.96 CYP1B1 PAX6
2 visual perception GO:0007601 8.62 CYP1B1 PAX6

Sources for Anterior Segment Dysgenesis 5

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....